Malaria Consortium   Report issue

Foundation Phase 4
Founded: London United Kingdom (2003)

Organization Overview

First Clinical Trial
2009
NCT00720811
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now